Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

BACKGROUND: Long-term safety, pharmacokinetics, and efficacy of open-label golimumab therapy in children with moderate–severe ulcerative colitis were evaluated. METHODS: Week-6 golimumab responders (Mayo score decrease of ≥30% and ≥3 points from baseline, rectal bleeding subscore of 0/1 or ≥1 decrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hyams, Jeffrey S, O’Brien, Christopher D, Padgett, Lakshmi, Rosh, Joel R, Turner, Dan, Veereman, Genevieve, Griffiths, Anne M, Heyman, Melvin B, Wahbeh, Ghassan, Adedokun, Omoniyi J, Strauss, Richard S, Lynch, John P, Chan, Daphne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802358/
https://www.ncbi.nlm.nih.gov/pubmed/36777743
http://dx.doi.org/10.1093/crocol/otaa063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802358/
https://www.ncbi.nlm.nih.gov/pubmed/36777743
http://dx.doi.org/10.1093/crocol/otaa063

Ejemplares similares